ERIS NSE filing

Eris Lifesciences to hold 20th AGM on Sep 25, 2026, via VC

The RealCase readLow impact Neutral

Eris Lifesciences will hold its 20th AGM on September 25, 2026, via video conferencing. The agenda includes adopting FY26 financial statements and re-appointing directors. Remuneration for cost auditors for FY27 is proposed at ₹3,66,000. Mr. Sujesh Vasudevan is proposed for a second term as Independent Director.

Why it matters

This announcement pertains to the scheduling and agenda of the Annual General Meeting, which is a regular corporate event. The items on the agenda are standard procedural matters and do not represent significant new developments or changes in the company's business operations or financial outlook.

The market read

The announcement is a routine procedural notice regarding the Annual General Meeting, including standard business items like financial statement adoption and director re-appointments. It does not contain any new financial performance data or strategic shifts that would indicate a positive or negative sentiment.

Eris Lifesciences Limited has announced that its Twentieth Annual General Meeting (20th AGM) will be held on Friday, September 25, 2026, at 11:00 A.M. The meeting will be conducted entirely through video conferencing (VC) in compliance with circulars from the Ministry of Corporate Affairs and SEBI.

The AGM agenda includes the consideration and adoption of the Audited Standalone and Consolidated Financial Statements for the Financial Year ended March 31, 2026, along with the reports of the Board of Directors and Auditors. The members will also vote on the re-appointment of Mr. Kaushal Kamlesh Shah as a Director retiring by rotation.

Furthermore, the meeting will address special business items. These include the ratification of remuneration for the Cost Auditors, M/s. Kiran J Mehta & Co., for the Financial Year ending March 31, 2027, with a proposed remuneration of ₹3,66,000. Additionally, the re-appointment of Mr. Sujesh Vasudevan as an Independent Director for a second term of five years, from July 25, 2027, to July 24, 2032, will be proposed as a special resolution.

The Annual Report for FY 2025-26 and the Notice of the AGM will be dispatched to all registered members. The company has engaged MUFG Intime India Private Limited for conducting the AGM and facilitating e-voting. The remote e-voting period will commence on Tuesday, September 22, 2026, and conclude on Thursday, September 24, 2026. The cut-off date for determining eligibility for e-voting is Friday, September 18, 2026.

Primary source

A plain-language summary of a public exchange filing by Eris Lifesciences Limited. Read the original for the full detail.

View original filing
This is RealCase

Every move, explained.

Expert model portfolios with exact weights, an Active or Hold state on every holding, and a written reason behind every change. In your pocket.

Coming soon toApp StoreComing soon toGoogle Play
100% digital · your money stays in your own broker · your data is secure
RealCase
Your RealCases
Core Compounders
Stocks
13.4%
Flexi Core
Mutual Funds
13.1%
Latest change
ActiveHDFC Bank10% → 14%

“Deposits growing faster than loans again. We add on strength, funded from cash.”

₹0Commission · fee-only